of September 30, 2017 is lower to 1.5 times. The proceed was primarily used to repay corporate loan from financial institutions in an aggregate amount of Baht 4,600 million and loan from shareholder in

year more than 20% (additional) To: President The Stock Exchange of Thailand Rich Asia Corporation Public Company Limited and subsidiaries would like to clarify the results of the quarter ended March 31

2017 To : Directors and Manager The Stock Exchange of Thailand According to the resolution of the meeting of the Board of Directors No.8/2017 of Wattanapat Hospital Trang Public Company Limited (“the

Attention: President The Stock Exchange of Thailand Regarding to JAS Asset Public Company Limited (“the Company”) Board of Meeting No.2/2019 on 8 May 2019, the resolution to certify the Company’s financial

(Translation) UAC.CS/010/2019 May 10, 2019 Subject: Explanation of the operating results for the first quarter period ended March 31, 2019 To: President The Stock Exchange of Thailand Attachment

explanation and analysis for three-month period ended 31 March 2019 Attention: The President of, The Stock Exchange of Thailand ZIGA Innovation Public Company Limited ( “ the Company” ) would like to clarify

: Management explanation and analysis for the 2nd Quarter ended 30 June 2018 Attention : The President of, The Stock Exchange of Thailand ZIGA Innovation Public Company Limited (“ the Company”) would like to

/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

ended June 30, 2018. To The President of The Stock Exchange of Thailand Origin Property Public Company Limited and its subsidiaries hereinafter called “The Group” For the 6 months period ended June 30

ที่ FPI Ref. FPI.007/2020 15 July 2020 Subject : Management Discussion & Analysis of Performance Results of Quarter 1 2020 To : Board of Directors and President of The Stock Exchange of Thailand